Opportunities and challenges in the treatment of IgA nephropathy
The treatment paradigm of immunoglobulin A nephropathy (IgAN) is shifting, and traditional therapeutic strategies are insufficient to meet clinical needs. Based on the increasing understanding of the pathogenesis of IgAN, current treatment goals concentrate on anti-inflammatory and targeted therapy,...
Saved in:
| Main Authors: | Yang Yang, Gaosi Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1559593/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of agents for IgA nephropathy: a network meta-analysis of randomized controlled trials
by: Bo Chen, et al.
Published: (2025-06-01) -
Study on the relationship between plasma Gd-IgA1 concentration and disease severity in IgA nephropathy and its production mechanism
by: DAI Qin, et al.
Published: (2020-01-01) -
A Targeted-Release Formulation of Budesonide for the Treatment of IgA Nephropathy Patients With Severe Renal Impairment
by: Yan Ouyang, et al.
Published: (2025-03-01) -
Differential expression of microRNAs in peripheral B lymphocytes in patients with IgA nephropathy and its clinical significance
by: WANG Qian-liao, et al.
Published: (2016-01-01) -
Hydroxychloroquine sulfate for IgA nephropathy: mechanisms and therapeutic potential in improving proteinuria and alleviating disease progression - a literature review
by: Liao Yilei, et al.
Published: (2025-07-01)